Convalescent Plasma for Outpatients with Covid-19. Reply
N Engl J Med
.
2021 Dec 2;385(23):2206-2207.
doi: 10.1056/NEJMc2114591.
Epub 2021 Oct 13.
Authors
Frederick K Korley
1
,
Valerie Durkalski-Mauldin
2
,
Clifton W Callaway
3
Affiliations
1
University of Michigan, Ann Arbor, MI.
2
Medical University of South Carolina, Charleston, SC.
3
University of Pittsburgh, Pittsburgh, PA callawaycw@upmc.edu.
PMID:
34644469
PMCID:
PMC11723561
DOI:
10.1056/NEJMc2114591
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Serotherapy
COVID-19* / therapy
Humans
Immunization, Passive
Outpatients*
SARS-CoV-2
Treatment Outcome
Grants and funding
OT2 HL156812/HL/NHLBI NIH HHS/United States
U24 NS100655/NS/NINDS NIH HHS/United States
U24 NS100657/NS/NINDS NIH HHS/United States
U24 NS100659/NS/NINDS NIH HHS/United States